{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:52:03Z","timestamp":1787003523196,"version":"build-2736575974"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T00:00:00Z","timestamp":1549929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T00:00:00Z","timestamp":1549929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI102838"],"award-info":[{"award-number":["AI102838"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI102838"],"award-info":[{"award-number":["AI102838"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI102838"],"award-info":[{"award-number":["AI102838"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI102838"],"award-info":[{"award-number":["AI102838"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI117739"],"award-info":[{"award-number":["AI117739"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health &amp; Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI102838"],"award-info":[{"award-number":["AI102838"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Tenofovir (TFV) treatment of female reproductive tract (FRT) cells results in differential accumulation of intracellular Tenofovir diphosphate (TFV-DP) in different cell types, with greater concentrations in epithelial cells (100-fold) and fibroblasts (10-fold) than in CD4+ T cells. The possibility that TFV-DP accumulation and retention in epithelial cells and fibroblasts may alter TFV availability and protection of CD4+ T cells against HIV infection, prompted us to evaluate TFV and\/or Tenofovir alafenamide (TAF) release from FRT cells. Endometrial, endocervical and ectocervical polarized epithelial cells and fibroblasts were pre-loaded with TFV or TAF, and secretions tested for their ability to inhibit HIV infection of activated blood CD4+ T cells. Epithelial cell basolateral secretions (1, 2 and 3 days post-loading), but not apical secretions, suppressed HIV infection of CD4+ T cells, as did secretions from pre-loaded fibroblasts from each site. Intracellular TFV-DP levels in epithelial cells following preloading with TFV or TAF correlated directly with ARV protection of CD4+ T cells from HIV infection. When added apically to epithelial cells, TFV\/TAF was released basolaterally, in part through Multidrug Resistant Protein transporters, taken up by fibroblasts and released into secretions to partially protect CD4+ T cells. These findings demonstrate that epithelial cells and fibroblasts release TFV\/TAF for use by CD4+ T cells and suggest that the tissue environment plays a major role in the sustained protection against HIV infection.<\/jats:p>","DOI":"10.1038\/s41598-018-38205-y","type":"journal-article","created":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T06:05:20Z","timestamp":1549951520000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Epithelial Cells and Fibroblasts from the Human Female Reproductive Tract Accumulate and Release TFV and TAF to Sustain Inhibition of HIV Infection of CD4+ T cells"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2365-2602","authenticated-orcid":false,"given":"Zheng","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Rodriguez-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mickey V.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Bodwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles R.","family":"Wira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,12]]},"reference":[{"key":"38205_CR1","unstructured":"WHO. Number of people (all ages) living with HIV: Estimates by WHO region, http:\/\/apps.who.int\/gho\/data\/view.main.22100WHO?lang=en (2018)."},{"key":"38205_CR2","unstructured":"UNAIDS. Women, girls, gender equality and HIV. (2010)."},{"key":"38205_CR3","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nri3819","volume":"15","author":"CR Wira","year":"2015","unstructured":"Wira, C. R., Rodriguez-Garcia, M. & Patel, M. V. The role of sex hormones in immune protection of the female reproductive tract. Nat Rev Immunol 15, 217\u2013230, https:\/\/doi.org\/10.1038\/nri3819 (2015).","journal-title":"Nat Rev Immunol"},{"key":"38205_CR4","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1038\/mi.2014.26","volume":"7","author":"M Rodriguez-Garcia","year":"2014","unstructured":"Rodriguez-Garcia, M., Barr, F. D., Crist, S. G., Fahey, J. V. & Wira, C. R. Phenotype and susceptibility to HIV infection of CD4+ Th17 cells in the human female reproductive tract. Mucosal Immunol 7, 1375\u20131385, https:\/\/doi.org\/10.1038\/mi.2014.26 (2014).","journal-title":"Mucosal Immunol"},{"key":"38205_CR5","doi-asserted-by":"publisher","first-page":"e62069","DOI":"10.1371\/journal.pone.0062069","volume":"8","author":"M Rodriguez-Garcia","year":"2013","unstructured":"Rodriguez-Garcia, M. et al. Estradiol reduces susceptibility of CD4+ T cells and macrophages to HIV-infection. PLoS One 8, e62069, https:\/\/doi.org\/10.1371\/journal.pone.0062069 (2013).","journal-title":"PLoS One"},{"key":"38205_CR6","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/mi.2016.72","volume":"10","author":"M Rodriguez-Garcia","year":"2017","unstructured":"Rodriguez-Garcia, M. et al. Dendritic cells from the human female reproductive tract rapidly capture and respond to HIV. Mucosal Immunol 10, 531\u2013544, https:\/\/doi.org\/10.1038\/mi.2016.72 (2017).","journal-title":"Mucosal Immunol"},{"key":"38205_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/srep45725","volume":"8","author":"M Rodriguez-Garcia","year":"2017","unstructured":"Rodriguez-Garcia, M. et al. Tenofovir Inhibits Wound Healing of Epithelial Cells and Fibroblasts from the Upper and Lower Human Female Reproductive Tract. Sci Rep 8, 45725, https:\/\/doi.org\/10.1038\/srep45725 (2017).","journal-title":"Sci Rep"},{"key":"38205_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-18078-3","volume":"7","author":"Z Shen","year":"2017","unstructured":"Shen, Z. et al. Hormonal Contraceptives Differentially Suppress TFV and TAF Inhibition of HIV Infection and TFV-DP in Blood and Genital Tract CD4+ T cells. Sci Rep 7, 17697, https:\/\/doi.org\/10.1038\/s41598-017-18078-3 (2017).","journal-title":"Sci Rep"},{"key":"38205_CR9","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/aji.12532","volume":"76","author":"Z Shen","year":"2016","unstructured":"Shen, Z., Rodriguez-Garcia, M., Patel, M. V., Barr, F. D. & Wira, C. R. Menopausal status influences the expression of programmed death (PD)-1 and its ligand PD-L1 on immune cells from the human female reproductive tract. Am J Reprod Immunol 76, 118\u2013125, https:\/\/doi.org\/10.1111\/aji.12532 (2016).","journal-title":"Am J Reprod Immunol"},{"key":"38205_CR10","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1038\/s41385-018-0045-0","volume":"11","author":"FD Barr","year":"2018","unstructured":"Barr, F. D., Ochsenbauer, C., Wira, C. R. & Rodriguez-Garcia, M. Neutrophil extracellular traps prevent HIV infection in the female genital tract. Mucosal Immunol 11, 1420\u20131428, https:\/\/doi.org\/10.1038\/s41385-018-0045-0 (2018).","journal-title":"Mucosal Immunol"},{"key":"38205_CR11","unstructured":"Organization, W. H. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV (2015)."},{"key":"38205_CR12","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1056\/NEJMoa1108524","volume":"367","author":"JM Baeten","year":"2012","unstructured":"Baeten, J. M. et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. The New England journal of medicine 367, 399\u2013410, https:\/\/doi.org\/10.1056\/NEJMoa1108524 (2012).","journal-title":"The New England journal of medicine"},{"key":"38205_CR13","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","volume":"363","author":"RM Grant","year":"2010","unstructured":"Grant, R. M. et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. The New England journal of medicine 363, 2587\u20132599, https:\/\/doi.org\/10.1056\/NEJMoa1011205 (2010).","journal-title":"The New England journal of medicine"},{"key":"38205_CR14","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1056\/NEJMoa1110711","volume":"367","author":"MC Thigpen","year":"2012","unstructured":"Thigpen, M. C. et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. The New England journal of medicine 367, 423\u2013434, https:\/\/doi.org\/10.1056\/NEJMoa1110711 (2012).","journal-title":"The New England journal of medicine"},{"key":"38205_CR15","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1126\/science.1193748","volume":"329","author":"Q Abdool Karim","year":"2010","unstructured":"Abdool Karim, Q. et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 329, 1168\u20131174, https:\/\/doi.org\/10.1126\/science.1193748 (2010).","journal-title":"Science"},{"key":"38205_CR16","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa1402269","volume":"372","author":"JM Marrazzo","year":"2015","unstructured":"Marrazzo, J. M. et al. Tenofovir-based preexposure prophylaxis for HIV infection among African women. The New England journal of medicine 372, 509\u2013518, https:\/\/doi.org\/10.1056\/NEJMoa1402269 (2015).","journal-title":"The New England journal of medicine"},{"key":"38205_CR17","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1202614","volume":"367","author":"L Van Damme","year":"2012","unstructured":"Van Damme, L. et al. Preexposure prophylaxis for HIV infection among African women. The New England journal of medicine 367, 411\u2013422, https:\/\/doi.org\/10.1056\/NEJMoa1202614 (2012).","journal-title":"The New England journal of medicine"},{"key":"38205_CR18","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1128\/AAC.02793-15","volume":"60","author":"E Taneva","year":"2015","unstructured":"Taneva, E. et al. Differential Mechanisms of Tenofovir and Tenofovir Disoproxil Fumarate Cellular Transport and Implications for Topical Preexposure Prophylaxis. Antimicrob Agents Chemother 60, 1667\u20131675, https:\/\/doi.org\/10.1128\/AAC.02793-15 (2015).","journal-title":"Antimicrob Agents Chemother"},{"key":"38205_CR19","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1124\/pr.110.003459","volume":"63","author":"KM Huttunen","year":"2011","unstructured":"Huttunen, K. M., Raunio, H. & Rautio, J. Prodrugs\u2013from serendipity to rational design. Pharmacol Rev 63, 750\u2013771, https:\/\/doi.org\/10.1124\/pr.110.003459 (2011).","journal-title":"Pharmacol Rev"},{"key":"38205_CR20","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.antiviral.2015.11.009","volume":"125","author":"AS Ray","year":"2016","unstructured":"Ray, A. S., Fordyce, M. W. & Hitchcock, M. J. Tenofovir alafenamide: A novel prodrug of tenofovir for the treatment of Human Immunodeficiency Virus. Antiviral Res 125, 63\u201370, https:\/\/doi.org\/10.1016\/j.antiviral.2015.11.009 (2016).","journal-title":"Antiviral Res"},{"key":"38205_CR21","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s11095-006-9196-x","volume":"24","author":"Y Uwai","year":"2007","unstructured":"Uwai, Y., Ida, H., Tsuji, Y., Katsura, T. & Inui, K. Renal transport of adefovir, cidofovir, and tenofovir by SLC22A family members (hOAT1, hOAT3, and hOCT2). Pharm Res 24, 811\u2013815, https:\/\/doi.org\/10.1007\/s11095-006-9196-x (2007).","journal-title":"Pharm Res"},{"key":"38205_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bcp.2016.04.015","volume":"119","author":"E De Clercq","year":"2016","unstructured":"De Clercq, E. Tenofovir alafenamide (TAF) as the successor of tenofovir disoproxil fumarate (TDF). Biochem Pharmacol 119, 1\u20137, https:\/\/doi.org\/10.1016\/j.bcp.2016.04.015 (2016).","journal-title":"Biochem Pharmacol"},{"key":"38205_CR23","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1128\/AAC.00968-06","volume":"51","author":"G Birkus","year":"2007","unstructured":"Birkus, G. et al. Cathepsin A is the major hydrolase catalyzing the intracellular hydrolysis of the antiretroviral nucleotide phosphonoamidate prodrugs GS-7340 and GS-9131. Antimicrob Agents Chemother 51, 543\u2013550, https:\/\/doi.org\/10.1128\/AAC.00968-06 (2007).","journal-title":"Antimicrob Agents Chemother"},{"key":"38205_CR24","doi-asserted-by":"publisher","first-page":"e100863","DOI":"10.1371\/journal.pone.0100863","volume":"9","author":"Z Shen","year":"2014","unstructured":"Shen, Z. et al. Sex hormones regulate tenofovir-diphosphate in female reproductive tract cells in culture. PLoS One 9, e100863, https:\/\/doi.org\/10.1371\/journal.pone.0100863 (2014).","journal-title":"PLoS One"},{"key":"38205_CR25","doi-asserted-by":"publisher","first-page":"e0185633","DOI":"10.1371\/journal.pone.0185633","volume":"12","author":"O Chuchuen","year":"2017","unstructured":"Chuchuen, O. et al. Label-free analysis of tenofovir delivery to vaginal tissue using co-registered confocal Raman spectroscopy and optical coherence tomography. PLoS One 12, e0185633, https:\/\/doi.org\/10.1371\/journal.pone.0185633 (2017).","journal-title":"PLoS One"},{"key":"38205_CR26","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1364\/BOE.6.002022","volume":"6","author":"JR Maher","year":"2015","unstructured":"Maher, J. R. et al. Co-localized confocal Raman spectroscopy and optical coherence tomography (CRS-OCT) for depth-resolved analyte detection in tissue. Biomed Opt Express 6, 2022\u20132035, https:\/\/doi.org\/10.1364\/BOE.6.002022 (2015).","journal-title":"Biomed Opt Express"},{"key":"38205_CR27","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jconrel.2015.08.018","volume":"219","author":"M Hu","year":"2015","unstructured":"Hu, M., Patel, S. K., Zhou, T. & Rohan, L. C. Drug transporters in tissues and cells relevant to sexual transmission of HIV: Implications for drug delivery. J Control Release 219, 681\u2013696, https:\/\/doi.org\/10.1016\/j.jconrel.2015.08.018 (2015).","journal-title":"J Control Release"},{"key":"38205_CR28","doi-asserted-by":"publisher","first-page":"4405","DOI":"10.1021\/mp5005004","volume":"11","author":"C Grammen","year":"2014","unstructured":"Grammen, C. et al. Vaginal expression of efflux transporters and the potential impact on the disposition of microbicides in vitro and in rabbits. Mol Pharm 11, 4405\u20134414, https:\/\/doi.org\/10.1021\/mp5005004 (2014).","journal-title":"Mol Pharm"},{"key":"38205_CR29","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/jcph.248","volume":"54","author":"MR Nicol","year":"2014","unstructured":"Nicol, M. R. et al. Expression of six drug transporters in vaginal, cervical, and colorectal tissues: Implications for drug disposition in HIV prevention. J Clin Pharmacol 54, 574\u2013583, https:\/\/doi.org\/10.1002\/jcph.248 (2014).","journal-title":"J Clin Pharmacol"},{"key":"38205_CR30","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1089\/AID.2016.0008","volume":"32","author":"SM Seifert","year":"2016","unstructured":"Seifert, S. M. et al. Intracellular Tenofovir and Emtricitabine Anabolites in Genital, Rectal, and Blood Compartments from First Dose to Steady State. AIDS Res Hum Retroviruses 32, 981\u2013991, https:\/\/doi.org\/10.1089\/AID.2016.0008 (2016).","journal-title":"AIDS Res Hum Retroviruses"},{"key":"38205_CR31","doi-asserted-by":"publisher","first-page":"e55013","DOI":"10.1371\/journal.pone.0055013","volume":"8","author":"CW Hendrix","year":"2013","unstructured":"Hendrix, C. W. et al. MTN-001: randomized pharmacokinetic cross-over study comparing tenofovir vaginal gel and oral tablets in vaginal tissue and other compartments. PLoS One 8, e55013, https:\/\/doi.org\/10.1371\/journal.pone.0055013 (2013).","journal-title":"PLoS One"},{"key":"38205_CR32","doi-asserted-by":"publisher","first-page":"112re114","DOI":"10.1126\/scitranslmed.3003174","volume":"3","author":"KB Patterson","year":"2011","unstructured":"Patterson, K. B. et al. Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission. Science translational medicine 3, 112re114, https:\/\/doi.org\/10.1126\/scitranslmed.3003174 (2011).","journal-title":"Science translational medicine"},{"key":"38205_CR33","doi-asserted-by":"publisher","unstructured":"Rodriguez-Garcia, M., Fortier, J. M., Barr, F. D. & Wira, C. R. Isolation of Dendritic Cells from the Human Female Reproductive Tract for Phenotypical and Functional Studies. J Vis Exp, https:\/\/doi.org\/10.3791\/57100 (2018).","DOI":"10.3791\/57100"},{"key":"38205_CR34","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1089\/jir.2017.0038","volume":"38","author":"MV Patel","year":"2018","unstructured":"Patel, M. V., Shen, Z., Rossoll, R. M. & Wira, C. R. IL-27 Expression and Responsiveness in Human Uterine Epithelial Cells and Fibroblasts In Vitro and the Role of Estradiol. J Interferon Cytokine Res 38, 101\u2013110, https:\/\/doi.org\/10.1089\/jir.2017.0038 (2018).","journal-title":"J Interferon Cytokine Res"},{"key":"38205_CR35","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1093\/humrep\/deh806","volume":"20","author":"JV Fahey","year":"2005","unstructured":"Fahey, J. V., Schaefer, T. M., Channon, J. Y. & Wira, C. R. Secretion of cytokines and chemokines by polarized human epithelial cells from the female reproductive tract. Hum Reprod 20, 1439\u20131446, https:\/\/doi.org\/10.1093\/humrep\/deh806 (2005).","journal-title":"Hum Reprod"},{"key":"38205_CR36","doi-asserted-by":"publisher","first-page":"e69854","DOI":"10.1371\/journal.pone.0069854","volume":"8","author":"Z Shen","year":"2013","unstructured":"Shen, Z. et al. Estradiol regulation of nucleotidases in female reproductive tract epithelial cells and fibroblasts. PLoS One 8, e69854, https:\/\/doi.org\/10.1371\/journal.pone.0069854 (2013).","journal-title":"PLoS One"},{"key":"38205_CR37","doi-asserted-by":"publisher","first-page":"6444","DOI":"10.1128\/AAC.03270-14","volume":"58","author":"N Biswas","year":"2014","unstructured":"Biswas, N. et al. Effects of tenofovir on cytokines and nucleotidases in HIV-1 target cells and the mucosal tissue environment in the female reproductive tract. Antimicrob Agents Chemother 58, 6444\u20136453, https:\/\/doi.org\/10.1128\/AAC.03270-14 (2014).","journal-title":"Antimicrob Agents Chemother"},{"key":"38205_CR38","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1126\/science.3014648","volume":"233","author":"S Gartner","year":"1986","unstructured":"Gartner, S. et al. The role of mononuclear phagocytes in HTLV-III\/LAV infection. Science 233, 215\u2013219 (1986).","journal-title":"Science"},{"key":"38205_CR39","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3851\/IMP2311","volume":"18","author":"DC Sokal","year":"2013","unstructured":"Sokal, D. C. et al. Safety of tenofovir gel, a vaginal microbicide, in South African women: results of the CAPRISA 004 Trial. Antiviral therapy 18, 301\u2013310, https:\/\/doi.org\/10.3851\/IMP2311 (2013).","journal-title":"Antiviral therapy"},{"key":"38205_CR40","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1007\/s11095-005-6810-2","volume":"22","author":"K Ito","year":"2005","unstructured":"Ito, K., Suzuki, H., Horie, T. & Sugiyama, Y. Apical\/basolateral surface expression of drug transporters and its role in vectorial drug transport. Pharm Res 22, 1559\u20131577, https:\/\/doi.org\/10.1007\/s11095-005-6810-2 (2005).","journal-title":"Pharm Res"},{"key":"38205_CR41","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1093\/jac\/dkm353","volume":"60","author":"O Janneh","year":"2007","unstructured":"Janneh, O., Jones, E., Chandler, B., Owen, A. & Khoo, S. H. Inhibition of P-glycoprotein and multidrug resistance-associated proteins modulates the intracellular concentration of lopinavir in cultured CD4 T cells and primary human lymphocytes. J Antimicrob Chemother 60, 987\u2013993, https:\/\/doi.org\/10.1093\/jac\/dkm353 (2007).","journal-title":"J Antimicrob Chemother"},{"key":"38205_CR42","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1093\/jac\/dkx064","volume":"72","author":"ML Cottrell","year":"2017","unstructured":"Cottrell, M. L. et al. Single-dose pharmacokinetics of tenofovir alafenamide and its active metabolite in the mucosal tissues. J Antimicrob Chemother 72, 1731\u20131740, https:\/\/doi.org\/10.1093\/jac\/dkx064 (2017).","journal-title":"J Antimicrob Chemother"},{"key":"38205_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-23062-6","volume":"8","author":"PC Benias","year":"2018","unstructured":"Benias, P. C. et al. Structure and Distribution of an Unrecognized Interstitium in Human Tissues. Sci Rep 8, 4947, https:\/\/doi.org\/10.1038\/s41598-018-23062-6 (2018).","journal-title":"Sci Rep"},{"key":"38205_CR44","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jsbmb.2004.11.002","volume":"93","author":"JV Fahey","year":"2005","unstructured":"Fahey, J. V., Rossoll, R. M. & Wira, C. R. Sex hormone regulation of anti-bacterial activity in rat uterine secretions and apical release of anti-bacterial factor(s) by uterine epithelial cells in culture. J Steroid Biochem Mol Biol 93, 59\u201366, https:\/\/doi.org\/10.1016\/j.jsbmb.2004.11.002 (2005).","journal-title":"J Steroid Biochem Mol Biol"},{"key":"38205_CR45","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/mi.2010.72","volume":"4","author":"CR Wira","year":"2011","unstructured":"Wira, C. R. et al. Epithelial cell secretions from the human female reproductive tract inhibit sexually transmitted pathogens and Candida albicans but not Lactobacillus. Mucosal Immunol 4, 335\u2013342, https:\/\/doi.org\/10.1038\/mi.2010.72 (2011).","journal-title":"Mucosal Immunol"},{"key":"38205_CR46","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1093\/jnci\/92.16.1295","volume":"92","author":"P Borst","year":"2000","unstructured":"Borst, P., Evers, R., Kool, M. & Wijnholds, J. A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst 92, 1295\u20131302 (2000).","journal-title":"J Natl Cancer Inst"},{"key":"38205_CR47","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1177\/0091270005278949","volume":"45","author":"BP Kearney","year":"2005","unstructured":"Kearney, B. P., Ramanathan, S., Cheng, A. K., Ebrahimi, R. & Shah, J. Systemic and renal pharmacokinetics of adefovir and tenofovir upon coadministration. J Clin Pharmacol 45, 935\u2013940, https:\/\/doi.org\/10.1177\/0091270005278949 (2005).","journal-title":"J Clin Pharmacol"},{"key":"38205_CR48","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1093\/cid\/civ913","volume":"62","author":"BC Herold","year":"2016","unstructured":"Herold, B. C. et al. Impact of Sex on the Pharmacokinetics and Pharmacodynamics of 1% Tenofovir Gel. Clin Infect Dis 62, 375\u2013382, https:\/\/doi.org\/10.1093\/cid\/civ913 (2016).","journal-title":"Clin Infect Dis"},{"key":"38205_CR49","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nm.4506","volume":"24","author":"LR McKinnon","year":"2018","unstructured":"McKinnon, L. R. et al. Genital inflammation undermines the effectiveness of tenofovir gel in preventing HIV acquisition in women. Nat Med 24, 491\u2013496, https:\/\/doi.org\/10.1038\/nm.4506 (2018).","journal-title":"Nat Med"},{"key":"38205_CR50","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/QAD.0000000000001678","volume":"32","author":"MR Nicol","year":"2018","unstructured":"Nicol, M. R., Brewers, L. M., Kashuba, A. D. M. & Sykes, C. The role of menopause in tenofovir diphosphate and emtricitabine triphosphate concentrations in cervical tissue. AIDS 32, 11\u201315, https:\/\/doi.org\/10.1097\/QAD.0000000000001678 (2018).","journal-title":"AIDS"},{"key":"38205_CR51","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1126\/science.aai9383","volume":"356","author":"NR Klatt","year":"2017","unstructured":"Klatt, N. R. et al. Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women. Science 356, 938\u2013945, https:\/\/doi.org\/10.1126\/science.aai9383 (2017).","journal-title":"Science"},{"key":"38205_CR52","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s11904-015-0269-5","volume":"12","author":"R Kaul","year":"2015","unstructured":"Kaul, R. et al. Inflammation and HIV Transmission in Sub-SaharanAfrica. Curr HIV\/AIDS Rep 12, 216\u2013222, https:\/\/doi.org\/10.1007\/s11904-015-0269-5 (2015).","journal-title":"Curr HIV\/AIDS Rep"},{"key":"38205_CR53","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1093\/ije\/dyx045","volume":"46","author":"KM Wall","year":"2017","unstructured":"Wall, K. M. et al. Risk of heterosexual HIV transmission attributable to sexually transmitted infections and non-specific genital inflammation in Zambian discordant couples, 1994-2012. Int J Epidemiol 46, 1593\u20131606, https:\/\/doi.org\/10.1093\/ije\/dyx045 (2017).","journal-title":"Int J Epidemiol"},{"key":"38205_CR54","doi-asserted-by":"publisher","first-page":"e0129769","DOI":"10.1371\/journal.pone.0129769","volume":"10","author":"K Smith-McCune","year":"2015","unstructured":"Smith-McCune, K. et al. Unexpected Inflammatory Effects of Intravaginal Gels (Universal Placebo Gel and Nonoxynol-9) on the Upper Female Reproductive Tract: A Randomized Crossover Study. PLoS One 10, e0129769, https:\/\/doi.org\/10.1371\/journal.pone.0129769 (2015).","journal-title":"PLoS One"},{"key":"38205_CR55","doi-asserted-by":"publisher","first-page":"e9310","DOI":"10.1371\/journal.pone.0009310","volume":"5","author":"LC Rohan","year":"2010","unstructured":"Rohan, L. C. et al. In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide. PLoS One 5, e9310, https:\/\/doi.org\/10.1371\/journal.pone.0009310 (2010).","journal-title":"PLoS One"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-38205-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-38205-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-38205-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T01:01:51Z","timestamp":1671238911000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-38205-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,12]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["38205"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-38205-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,12]]},"assertion":[{"value":"1 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"1864"}}